Please find below a video abstract summarising the review article on the disease course of systemic sclerosis-associated interstitial lung disease and the implications for treatment.
 

Vonk MC, Walker UA, Volkmann ER, et al. Natural variability in the disease course of SSc-ILD: implications for treatment. Eur Respir Rev 2021; 30: 200340

DOI: 10.1183/16000617.0340-2020

Header - Navigation Icon

This review was supported by Boehringer Ingelheim International GmbH (BI). The authors meet criteria for authorship as recommended by the International Committee of Medical Journal Editors (ICMJE). The authors did not receive payment for the development of this video abstract. Writing support was provided by Chester Trinick and Claire Scott, of MediTech Media, UK, which was contracted and funded by BI. BI was given the opportunity to review the article for medical and scientific accuracy, as well as intellectual property considerations.